At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 264 enrolled
Drug / intervention
Ivermectin cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind Randomized Study to Compare the Safety, Local Tolerability and Efficacy of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation
In Brief
A Phase 2 clinical trial evaluating Ivermectin cream and vehicle control for Head Lice. Completed, enrolled 264 participants across 12 sites.
Detailed Summary
The purpose of this study is to compare the safety and efficacy of a 0.5% ivermectin cream to a placebo in subjects infested with head lice when used in an "at home" environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead Lice
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedOct 2009
Primary CompletionDec 2009
TodayJul 2026
First PostedOct 14, 2009
Enrollment StartOct 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.7 years ago
Interventions
Ivermectin creamdrug
Up to 4 ounces of topical 0.5% Ivermectin Cream applied to the hair and scalp on day 1.
vehicle controldrug
Up to 4 ounces of vehicle control applied to the hair and scalp on day 1